Agilent Agilent Rapid Fire HTS Technology for Determination of Serum Biomarkers (Amino Acids) For Gene Therapy
Agilent RapidFire 400
This system provides reliable high throughput and accurate measurements for the qualification of drug targets like automated ADME in discovery, compound binding assessment, elucidation of metabolic processes, the discovery of novel metabolomics targets, and much more. Fully controlled by a single PC, the RapidFire 400 can be combined with any Agilent LC/Q-TOF or LC/TQ, while integrating the Ultivo LC/TQ into the system dramatically reduces the footprint of the autosampler and mass spec combination.
- Studying ADME for drug discovery
- Measurement of Phenylalanine and Tyrosine for PKU Gene Therapy (Homology Therapeutics)
- Study posttranslational modification of proteins
Ahmed et al, 2020, Methods and Clinical Development